首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1391957

中和抗体市场，按抗体类型，按目标病毒，按应用，按最终用户，按配销通路，按地区

Neutralizing Antibody Market, By Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, Target Virus: SARS-CoV-2, HIV, Influenza, Ebola, Zika, Hepatitis C, Others, Application, End User, Distribution Channel, Geography

出版日期: 2023年10月30日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年全球中和抗体市场规模为1,904.4亿美元，预计2030年将达到3,388.6亿美元，2023年至2030年复合年增长率为8.6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	1904.4亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	8.60%	2030年市场规模预测	3388.6亿美元

图 1. 2023 年中和抗体的全球市场占有率(%)（按地区）

中和抗体是先天免疫的重要组成部分，由自然感染和疫苗接种诱导。这些抗体可辨识病毒的特定部分并阻止其结合和感染细胞。由于其特殊的结构，抗体可以与病毒刺突蛋白上的受体结合域（RBD）结合，阻止其与宿主细胞受体结合，从而促进病毒进入细胞。

市场动态：

全球中和抗体市场预计在预测期内将快速成长。这种成长的主要驱动力之一是肝炎、爱滋病毒和结核病等感染疾病的高盛行率。多种治疗性单株抗体的可用性也是推动市场成长的因素之一。此外，引入先进技术来开发单株抗体预计将推动该市场的成长。然而，这些测试的高成本可能会限制其采用，从而阻碍市场成长。

本研究的主要特点

本报告对全球中和抗体市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球中和抗体市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球中和抗体市场的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 190.44 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.60%	2030 Value Projection:	US$ 338.86 Bn

Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.

Market Dynamics:

The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.

Key features of the study:

This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market

Neutralizing Antibody Market Detailed Segmentation:

By Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
By Target Virus:
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
By Application:
- Therapeutics
- Diagnostics
- Research and Development
By End User:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
By Distribution Channel:
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- COVID-19 Pandemic
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Neutralizing Antibody Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Neutralizing Antibody Market , By Antibody Type, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Bn)
Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Bn)

6. Neutralizing Antibody Market , By Target Virus, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
SARS-CoV-2 (COVID-19)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

7. Neutralizing Antibody Market , By Application, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

8. Neutralizing Antibody Market , By End User, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

9. Neutralizing Antibody Market , By Distribution Channel, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

10. Neutralizing Antibody Market , By Region, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
GCC
Israel
North Africa
Central Africa
Rest of Middle East & Africa

11. Competitive Landscape

Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
AstraZeneca PLC
GlaxoSmithKline plc
Sanofi SA
Roche Holding AG
Novartis AG
Merck & Co., Inc.
Pfizer Inc.
Johnson & Johnson
Takeda Pharmaceutical Company Limited
Moderna, Inc.
BioNTech SE
CSL Limited
Sinovac Biotech Ltd.
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

中和抗体市场，按抗体类型，按目标病毒，按应用，按最终用户，按配销通路，按地区